News

Aquinnah Pharmaceuticals announced that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke (NINDS) in a competing grant to advance novel…
Read More...

MaaT Pharma announced a licensing agreement under which MaaT Pharma will receive world-wide exclusive rights for the therapeutic application of allogeneic Fecal Microbiome Transplants…
Read More...

ImmunoGen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead program, mirvetuximab soravtansine. The designation is for the…
Read More...

Sanofi and Ablynx announced today that Sanofi has now acquired all outstanding shares (including shares represented by American Depositary Shares (“ADSs”)), warrants and convertible…
Read More...

Merck announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line…
Read More...

Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO),…
Read More...

Following a global bidding process, Sharp selected Werum IT Solutions as its strategic MES partner to implement an Electronic Batch Record (EBR) infrastructure at its Netherlands…
Read More...

Crown Bioscience announces that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline. CrownBio…
Read More...

Pacira Pharmaceuticals, Inc. and Nuance Biotech Co. Ltd (Nuance) announced that they have entered into an agreement with Nuance, a China based specialty pharmaceutical company, to…
Read More...

Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant…
Read More...

Enamine Ltd. announced they have entered into a collaboration agreement. The partnership aims to manage the transition of chemical synthesis of novel intermediates from laboratory to…
Read More...

Grifols announced that it has received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays: Procleix Ultrio Elite and Procleix WNV. Procleix…
Read More...

Neptune Technologies & Bioressources Inc., announced that it entered into a multi-year agreement with Canopy Growth. Under the terms of the agreement, Neptune will supplement Canopy…
Read More...

Celltrion has made a resubmission to the FDA (U.S. Food and Drug Administration) to obtain its marketing approval for CT-P6, a proposed mAb biosimilar to Herceptin (trastuzumab).…
Read More...

Seattle Genetics announced dosing of the first patient in the phase 2 innovaTV 204 clinical trial evaluating the efficacy, safety and tolerability of tisotumab vedotin as monotherapy…
Read More...

Pharmacolog AB and HelioMetrics announced a new partnership that will deliver solutions designed to stop drug diversion and provide safe administration of IV medications for hospitals…
Read More...

Acerus Pharmaceuticals Corporation announced that Hyundai Pharm Co., Ltd. (Hyundai), Acerus’ licensee, reported that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved…
Read More...

STA Pharmaceutical, a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug Administration of China (CNDA, former CFDA) of its Category…
Read More...

Prana Biotechnology received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the…
Read More...

Catalent Pharma Solutions announced that it has appointed Mr. Paul Hegwood as President of the company’s Clinical Supply Services business. He succeeds Mr. Wetteny Joseph, who was named…
Read More...